AstraZeneca resumes UK trials of Covid-19 vaccine halted by patient illness
AstraZeneca has resumed British clinical trials of its Covid-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday...
Would you like to comment on this article or view other readers' comments? Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.